Artios Pharma Competitors and Similar CompaniesClear all
Artios Pharma's competitors and similar companies include E&O Laboratories, Sangon Biotech and NovellusDx.
 Artios Pharma A new private company focused on developing novel cancer treatments targeting the DNA Damage Response |  Sangon Biotech Sangon Biotech (Shanghai) (生工生物工程(上海)股份有限公司) is a biotechnology company engaged in the research and development of chemical synthesis of DNA. |  NovellusDx NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression. | ||
Founding Date | Founding Date 2016 | Founding Date 1989 | Founding Date 1995 | Founding Date 2012 |
Type | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Cambridgeshire, GB HQ | Locations HQ | Locations Shanghai, CN HQ | Locations Jerusalem, IL HQ Philadelphia, US |
Employees | Employees N/A | Employees 58 | Employees 69 | Employees 49 |
Funding | ||||
Latest funding round | Latest funding round $ 83.6m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 6m (about 8 years ago) |
Total funding raised | Total funding raised $ 116.1m | Total funding raised N/A | Total funding raised $ 6.2m | Total funding raised $ 34.5m |
For sources of this data, please see the company profile
View Company Profiles
E&O Laboratories
HQ
Employees
58
E and O Laboratories is a provider of biotechnology services.
View companySangon Biotech
HQ
Shanghai, CN
Sangon Biotech (Shanghai) (生工生物工程(上海)股份有限公司) is a biotechnology company engaged in the research and development of chemical synthesis of DNA.
View companyNovellusDx
HQ
Jerusalem, IL
Employees
49
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
View company